Download PDF October 5, 2013 at 2:00 AM Researchers from the Norwegian University of Science and Technology have had promising experimental results from using Botox as a weight loss tool in rats. The research group hopes to win approval for human testing in the near future. You may know Botox from its use by the […]Continue Reading ...
Download PDF February 4, 2010 at 2:34 AM CanLiv: The Hepatobiliary Cancers Foundation in partnership with The Cholangiocarcinoma Foundation will host the 1st Annual Biliary Tract-Gallbladder Cancer Research Symposium on Friday, May 7, 2010 at the American Society of Clinical Oncologists (ASCO) headquarters in Alexandria, Virginia. “Treatment for all cancers requires a multi-disciplinary team” The […]Continue Reading ...
Download PDF June 23, 2007 at 2:22 AM Arpida Ltd. has announced that it has received approval from the US Food and Drug Administration for a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive […]Continue Reading ...
Download PDF December 7, 2015 at 7:42 AM World AIDS Day, held annually on the first day of December each year since 1988, is an opportunity for people around the world to join in the fight, show their support for those living with human immunodeficiency virus (HIV), and commemorate the lives of those who have […]Continue Reading ...
Download PDF February 6, 2017 at 5:33 AM Macrophages are a type of white blood cell that can engulf and destroy cancer cells. A research group led by Professor MATOZAKI Takashi, Associate Professor MURATA Yoji, and YANAGITA Tadahiko (Kobe University Department of Biochemistry and Molecular Biology, Division of Molecular and Cellular Signaling), discovered that by […]Continue Reading ...
Download PDF August 3, 2016 at 9:47 AM The Priory Group, the leading provider of mental healthcare in the UK, most commonly known for treating celebrities with addictions, has opened its first Wellbeing Centre in Cheadle, Great Manchester. Based in the grounds of The Priory Hospital Cheadle Royal, the Priory Wellbeing Centre Manchester will provide […]Continue Reading ...
Download PDF February 20, 2015 at 7:15 AM Women with multiple sclerosis (MS) may have lower levels of important antioxidant and anti-inflammatory nutrients, such as folate from food and vitamin E, than healthy people, according to a new study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in […]Continue Reading ...
Download PDF August 13, 2009 at 6:48 PM A multi-institutional team of Boston-area researchers has discovered a chemical that works in mice to kill the rare but aggressive cells within breast cancers that have the ability to seed new tumors. These cells, known as cancer stem cells, are thought to enable cancers to spread – and […]Continue Reading ...
Download PDF June 15, 2010 at 7:08 AM Inovio Pharmaceuticals, Inc. (NYSE Amex:INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X. This […]Continue Reading ...
Download PDF August 17, 2016 at 9:17 AM Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say. Testing rates for the disease — which affects almost 10 times more Australians than […]Continue Reading ...
Download PDF February 13, 2013 at 2:45 AM In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present data showing racial and ethnic disparities exist for adverse obstetric outcomes. In […]Continue Reading ...
Download PDF September 10, 2013 at 1:56 AM Researchers at UCLA’s Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments. The study was a collaboration between Dean Ho, […]Continue Reading ...
Download PDF October 25, 2016 at 10:37 AM Rutgers Cancer Institute of New Jersey resident research member Wenwei Hu, PhD, has received a $596,250 Breakthrough Award (W81XWH-16-1-0358) from the U.S. Department of Defense through its Breast Cancer Research Program to study the role of chronic stress in breast cancer development. The focus of the work […]Continue Reading ...
Download PDF March 17, 2011 at 4:53 AM Airborne radiation from a meltdown at Japanese nuclear plants poses no immediate risk to the continental United States, say University of Maryland public health and atmospheric scientists. Drawing on research from the Chernobyl meltdown in 1986, they add that for most Japanese, the long term risk may […]Continue Reading ...
Download PDF June 8, 2015 at 2:59 AM The flu kills hundreds of thousands of people around the world every year, yet there is essentially only one class of drugs to fight the ever-changing virus. Cases of flu resistant to this class of drugs have already been reported and researchers worry a completely new strain […]Continue Reading ...
- Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation
- A new mechanism in the control of inflammation
- Age-related decline in abstract reasoning ability predicts depressive symptoms over time
- Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
- Sugar, a ‘sweet’ tool to understand brain injuries
- Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
- Novel discovery could lead to new cancer, autoimmune disease therapy
- AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
- Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
- New pharmacological agent shows promise for prevention of heart rhythm disorders
- All That Social Media May Boost Loneliness, Not Banish It
- Scientists shine new light on link between obesity and cancer
- Risk factors for cardiovascular disease closely track with changes in diet patterns
- Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
- Detectable HIV-1 in treated human liver cells found to be inert
- Using light to control crucial step in embryonic development
- Unusual case of father-to-son HIV transmission reported
- FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
- Poverty blamed on widening north-south gap in young adult deaths in England
- Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows